Citations per year, relative to S Vadlamudi S Vadlamudi (= 1×)
peers
Bismarck B. Lozzio
Countries citing papers authored by S Vadlamudi
Since
Specialization
Citations
This map shows the geographic impact of S Vadlamudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Vadlamudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Vadlamudi more than expected).
This network shows the impact of papers produced by S Vadlamudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Vadlamudi. The network helps show where S Vadlamudi may publish in the future.
Co-authorship network of co-authors of S Vadlamudi
This figure shows the co-authorship network connecting the top 25 collaborators of S Vadlamudi.
A scholar is included among the top collaborators of S Vadlamudi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with S Vadlamudi. S Vadlamudi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Rk, Johnson, et al.. (1976). Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.. PubMed. 60(9). 1347–61.16 indexed citations
2.
Vadlamudi, S, et al.. (1973). Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.. PubMed. 33(9). 2014–9.21 indexed citations
3.
Nicolin, A, S Vadlamudi, & A Goldin. (1973). Increased immunogenicity of murine lymphatic tumors by pyrazole-4-carboxamide, 3(or 5)-amino (NSC-1402; PCA).. PubMed. 57(1). 3–10.9 indexed citations
Loos, Michael, S Vadlamudi, Monte S. Meltzer, et al.. (1972). Detection of endotoxin in commercial L-asparaginase preparations by complement fixation and separation by chromatography.. PubMed. 32(11). 2292–6.13 indexed citations
6.
Nicolin, A, S Vadlamudi, & Abraham Goldin. (1972). Antigenicity of L1210 leukemic sublines induced by drugs.. PubMed. 32(4). 653–7.50 indexed citations
7.
Vadlamudi, S, et al.. (1971). Effect of antitumor agents on leukemia l5178y and on l-asparaginase resistant variant in vitro. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory).1 indexed citations
Bonmassar, Enzo, A Nicolin, S Vadlamudi, I Kline, & A Goldin. (1971). Antigenic change in l1210 leukemic cells induced in vivo by two drugs. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 628.1 indexed citations
Vadlamudi, S, M Padarathsingh, V.S. Waravdekar, & A Goldin. (1970). Factors influencing the therapeutic activity of L-asparaginase (NSC 109229) in leukemic (L5178Y) mice.. PubMed. 30(5). 1467–72.8 indexed citations
13.
Bonmassar, Enzo, Gustavo Cudkowicz, S Vadlamudi, & A Goldin. (1970). Influence of tumor-host differences at a single histocompatibility locus (H-1) on the antileukemic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC 409962).. PubMed. 30(10). 2538–42.25 indexed citations
14.
Vadlamudi, S, M Padarathsingh, V.S. Waravdekar, & A Goldin. (1970). Combination chemotherapy with l-asparaginase (nsc 109,229) and cyclophosphamide (nsc 26,271, cytoxan) in mice bearing leukemia l5178y. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 80.3 indexed citations
Vadlamudi, S, et al.. (1970). Effect of combination treatment with 5-azacytidine and cytidine on the life-span and spleen and bone marrow cells of leukemic (L1210) and nonleukemic mice.. PubMed. 30(2). 362–9.17 indexed citations
17.
Vadlamudi, S, et al.. (1969). Reduction in therapeutic activity of l-asparaginase in leukemic (l5178) mice pretreated with the drug. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.